Guarding your Thyroid Health: Insights into Thyroid Cancer

The thyroid gland — a small, butterfly-shaped gland at the base of your neck — plays an outsized role in your health, regulating metabolism, energy, heart rate, and body temperature. Thyroid cancer is the most common endocrine malignancy, and its incidence is rising globally. Understanding the risk factors, symptoms, and the role of genetics in thyroid cancer is essential for early detection and effective management.

Types of Thyroid Cancer

• Papillary thyroid cancer (PTC): The most common type, accounting for approximately 80% of cases. Generally slow-growing with an excellent prognosis. Associated with BRAF V600E and RET/PTC rearrangements.
• Follicular thyroid cancer (FTC): Accounts for approximately 10–15% of cases. More likely to spread to distant sites than PTC. Associated with RAS mutations and PAX8-PPARG rearrangements.
• Medullary thyroid cancer (MTC): Arises from parafollicular C cells that produce calcitonin. Approximately 25% of MTC cases are hereditary, caused by RET proto-oncogene mutations. Associated with Multiple Endocrine Neoplasia type 2 (MEN2).
• Anaplastic thyroid cancer: Rare but highly aggressive. Often arises from dedifferentiation of PTC or FTC. Associated with TP53 mutations.

Risk Factors for Thyroid Cancer

• Radiation exposure: Particularly head and neck radiation in childhood. The strongest environmental risk factor.
• Female sex: Thyroid cancer is 3× more common in women than men, though the reason is not fully understood.
• Age: Risk increases with age, though thyroid cancer can occur at any age.
• Family history: A family history of thyroid cancer increases risk, particularly for medullary thyroid cancer.
• Genetic syndromes: MEN2 (RET mutations), familial adenomatous polyposis (APC mutations), Cowden syndrome (PTEN mutations), and Carney complex (PRKAR1A mutations) all increase thyroid cancer risk.

The Genetics of Thyroid Cancer

Hereditary Medullary Thyroid Cancer

Approximately 25% of medullary thyroid cancer cases are caused by inherited RET proto-oncogene mutations. These mutations cause MEN2A (MTC + hyperparathyroidism + pheochromocytoma), MEN2B (MTC + pheochromocytoma + mucosal neuromas + marfanoid habitus), and familial MTC (MTC only). Genetic testing for RET mutations is recommended for all MTC patients and their first-degree relatives. Prophylactic thyroidectomy is recommended for RET mutation carriers, with timing based on the specific mutation and its associated risk level.

Somatic Mutations in Thyroid Cancer

Most thyroid cancers are driven by somatic (acquired) mutations. BRAF V600E is found in approximately 60% of papillary thyroid cancers and is associated with more aggressive behavior. RAS mutations are found in follicular thyroid cancers and some papillary cancers. Molecular testing of thyroid nodule biopsies can help determine malignancy risk and guide surgical decisions.

Symptoms and Detection

Thyroid cancer often presents as a painless lump or nodule in the neck. Other symptoms include hoarseness, difficulty swallowing, swollen lymph nodes in the neck, and neck pain. Many thyroid cancers are discovered incidentally on imaging done for other reasons. Ultrasound is the primary imaging modality for thyroid nodule evaluation; fine-needle aspiration biopsy provides tissue for diagnosis.

FAQs

Should I get genetic testing if I have medullary thyroid cancer?

Yes. All patients with medullary thyroid cancer should have germline RET testing, as approximately 25% have an inherited mutation. If a RET mutation is found, first-degree relatives should be offered testing.

Can thyroid cancer be prevented?

For hereditary MTC caused by RET mutations, prophylactic thyroidectomy can prevent cancer development. For sporadic thyroid cancer, avoiding unnecessary radiation exposure is the primary preventive measure.